CLINICAL_TRIALS
trial_result
· 2011-09-20
Clinical Trial Update: A Prospective, Post-marketing Registry on the Use of ChondroMimetic for the Repair of Osteochondral Defects
Summary
A post-marketing registry evaluating the use of ChondroMimetic to repair osteochondral defects has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: TiGenix n.v. | Conditions: Osteochondral Defects | Status: TERMINATED